FIBROGEN INC (FGEN) Operating Income (Loss) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Fibrogen Inc quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Fibrogen Inc Operating Income (Loss) for the quarter ending March 31, 2024 was -$31.1 M, a 59.2% increase year-over-year.
  • Fibrogen Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was -$237 M, a 24.6% increase year-over-year.
  • Fibrogen Inc annual Operating Income (Loss) for 2023 was -$282 M, a 6.38% increase from 2022.
  • Fibrogen Inc annual Operating Income (Loss) for 2022 was -$301 M, a 4.33% decline from 2021.
  • Fibrogen Inc annual Operating Income (Loss) for 2021 was -$289 M, a 50.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$237 M -$31.1 M +$45 M +59.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$282 M -$54.2 M +$12 M +18.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 -$294 M -$63.5 M +$30.2 M +32.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$324 M -$88 M -$9.82 M -12.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$314 M -$76.1 M -$13.1 M -20.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$301 M -$66.2 M +$69.1 M +51.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 -$370 M -$93.7 M -$145 M -284% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$225 M -$78.2 M +$55.6 M +41.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$281 M -$63 M +$7.43 M +10.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$289 M -$135 M -$77.2 M -133% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$211 M $51 M +$18.6 M +57.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$230 M -$134 M -$48.7 M -57.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$181 M -$70.4 M +$10.6 M +13.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$192 M -$58 M +$42.4 M +42.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$234 M $32.3 M +$85.2 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$320 M -$85.1 M -$198 M -175% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$122 M -$81.1 M -$32.2 M -66% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$89.3 M -$100 M -$120 M -604% Oct 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
Q3 2019 $31 M -$52.9 M -$10.1 M -23.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $41.1 M $113 M +$136 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$94.9 M -$48.8 M -$8.24 M -20.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$86.7 M $19.9 M +$55.5 M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$142 M -$42.8 M -$20 M -88.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$122 M -$23.2 M +$6.9 M +22.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$129 M -$40.6 M -$11.8 M -40.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$117 M -$35.6 M -$7.92 M -28.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$109 M -$22.7 M -$637 K -2.88% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$109 M -$30.1 M -$56.7 M -214% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$52.1 M -$28.8 M -$2.04 M -7.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$50 M -$27.7 M +$20.8 M +42.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 -$70.8 M -$22.1 M +$21.7 M +49.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$92.5 M $26.5 M -$32.8 M -55.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$59.7 M -$26.8 M +$17.9 M +40.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$77.6 M -$48.4 M -$473 K -0.99% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 -$77.2 M -$43.8 M -$6.68 M -18% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$70.5 M $59.3 M +$10.1 M +20.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$80.6 M -$44.7 M -$30.5 M -215% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$50.1 M -$48 M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$37.1 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $49.2 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$14.2 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.